Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study
Table 2
Parasite clearance and fever clearance in number of patients during chloroquine therapy.
Time point
Parasite clearance (%)
Fever clearance (%)
At 6 hrs
NA
122 (33.9)
At 12 hrs
35 (9.7)
150 (41.7)
At 18 hrs
NA
159 (44.2)
At 24 hrs
117 (32.5)
173 (48.1)
At 30 hrs
NA
163 (45.3)
At 36 hrs
222 (61.7)
241 (66.9)
At 42 hrs
NA
284 (78.9)
At 48 hrs
281 (78.1)
314 (87.2)
At 54 hrs
NA
325 (90.3)
At 60 hrs
325 (90.3)
345 (95.8)
At 66 hrs
NA
349 (96.9)
At 72 hrs
358 (99.4)
352 (97.8)
At 78 hrs
NA
357 (99.2)
At 84 hrs
NA
358 (99.4)
The data includes all patients who were included to receive chloroquine therapy, NA: not applicable values.